ADAPTIMMUNE THERAPEUTICS PLC Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$22.64 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-10
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$22.64M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $16.96M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $5.74M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $5.62M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $17.75M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$58.84M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$1.37M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2017-03-31 | -$22.64M 10-Q · filed 2017-05-10 | -$5.68M derived: sum of 2 quarters · filed 2017-05-10 | $65.00K derived: sum of 3 quarters · filed 2017-05-10 | $5.68M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-12-31 | $16.96M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $22.70M derived: sum of 2 quarters · filed 2017-03-13 | $28.32M derived: sum of 3 quarters · filed 2017-03-13 | $17.75M 10-K · filed 2017-03-13 | |
| 2016-09-30 | $5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $11.36M derived: sum of 2 quarters · filed 2016-11-10 | $796.00K 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $5.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$4.95M 10-Q · filed 2016-08-08 | |||
| 2016-03-31 | -$10.56M 10-Q · filed 2017-05-10 | ||||
| 2015-12-31 | -$9.84M 10-K · filed 2017-03-13 | -$14.50M 10-Q · filed 2016-05-12 | |||
| 2015-09-30 | -$10.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$40.99M derived: sum of 2 quarters · filed 2016-11-10 | -$41.66M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$30.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$31.59M 10-Q · filed 2016-08-08 | -$58.84M 10-K · filed 2017-03-13 | ||
| 2015-03-31 | -$672.00K 10-Q · filed 2016-05-12 | ||||
| 2014-06-30 | -$1.37M 10-K · filed 2017-03-13 | ||||
| 2013-06-30 | -$167.00K 8-K · filed 2016-07-08 |